<html xml:lang="en-us" lang="en-us" xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops"><head>
    <link rel="stylesheet" type="text/css" href="../../css/base.css" />
<link rel="stylesheet" type="text/css" href="../../css/kotobeeInteractive.css" />
<link rel="stylesheet" type="text/css" href="../../css/global.css" />

    <script type="text/javascript" src="../../js/kotobeeInteractive.js"></script>
<script type="text/javascript" src="../../js/global.js"></script>

    <title>Clonidine</title>
    

<meta name="m-checksum" content="74998264" />
<meta charset="utf-8" />
 <meta name="kotobee-chapter" content="raw\sdbxqd.xhtml" />
<meta name="kotobee-book" content="urn:uuid:98f26448-4ebf-31a0-e8db-2dcb6af5fa49" />
</head>
<body>
<p><em><strong>Clonidine in palliative patients should only be used under the direction of a palliative care specialist. Speak to one before initiating clonidine.</strong></em></p>

<p><strong>Indication:</strong></p>

<ul>
	<li>Pain (especially neuropathic pain) refractory to other analgesia</li>
	<li>Refractory agitation or hyperactive delirium in the imminently dying patient (especially if antipsychotics are best avoided)</li>
</ul>

<p><strong>Contraindications and precautions:</strong></p>

<ul>
	<li>Bradycardia or heart block - contraindicated</li>
	<li>Hypotension</li>
	<li>Conditions that may be worsened by bradycardia or hypotension (for example, recent acute coronary syndrome, cerebrovascular disease)</li>
	<li>Raynaud’s phenomenon (may worsen)</li>
	<li>Renal impairment (use lower doses)</li>
	<li>Diabetes (may cause transient rise in blood glucose level)</li>
	<li>Depression (may be exacerbated)</li>
	<li>Patients taking mirtazapine (can reduce or prevent effect of clonidine due to α2 antagonism)</li>
</ul>

<p><strong>Before starting:</strong></p>

<ul>
	<li>Exclude contraindications by checking blood pressure and heart rate (if appropriate), and consider an ECG</li>
	<li>If using for pain, record a pain score prior to commencing loading or test dosing</li>
	<li>Communicate and gain consent</li>
</ul>

<p><strong>Commencing clonidine:</strong></p>

<ul>
	<li>Give an initial loading or test dose of clonidine 75mcg subcutaneously</li>
	<li>Assess response over 1-2 hours</li>
	<li>If effective
	<ul>
		<li>Commence a continuous subcutaneous infusion of 150mcg over 24 hours</li>
	</ul>
	</li>
	<li>If there was no benefit from initial loading or test dose after 2 hours
	<ul>
		<li>Give a second loading/test dose of clonidine 75mcg subcutaneously</li>
		<li>Assess response over 1-2 hours</li>
		<li>If effective, commence a continuous subcutaneous infusion of 300mcg over 24 hours</li>
	</ul>
	</li>
	<li>If no benefit, further doses are unlikely to be helpful and clonidine should be stopped</li>
	<li>If renal impairment (CrCl &lt;30mL/min), consider halving the above CSCI doses</li>
</ul>

<p><strong>Increasing the dose:</strong></p>

<ul>
	<li>If necessary, increase the dose of the infusion by 150mcg over 24 hours every 24-48 hours up to 900mcg over 24hours -&#160;monitor blood pressure or heart rate prior to any dose increase</li>
	<li>The typical effective dose is 300-600mcg over 24 hours</li>
</ul>

<p><strong>Converting to oral clonidine:</strong></p>

<ul>
	<li>There is little evidence to guide the duration of treatment</li>
	<li>If longer-term use is desired, conversion from subcutaneous to oral clonidine could be considered</li>
	<li>The oral bioavailability of clonidine is approximately 70-80% - a reasonable dose conversion would be 0.75:1 to 1:1&#160;</li>
</ul>

<p><strong>Stopping clonidine:</strong></p>

<ul>
	<li>Use caution when stopping clonidine abruptly after long-term treatment as there is a risk of a severe withdrawal syndrome (which can be worsened if also taking beta-blockers)</li>
	<li>Wean over 2-4 days (if subcutaneous infusion) or 7 days (if using oral clonidine)</li>
</ul>

<p><strong>Adverse effects:</strong></p>

<ul>
	<li>Cardiovascular
	<ul>
		<li>Hypotension</li>
		<li>Bradycardia</li>
	</ul>
	</li>
	<li>Neurological
	<ul>
		<li>Sedation/fatigue</li>
		<li>Nightmares</li>
	</ul>
	</li>
	<li>Gastrointestinal
	<ul>
		<li>Dry mouth</li>
		<li>Constipation</li>
		<li>Nausea, vomiting</li>
	</ul>
	</li>
</ul>


</body></html>